This abnormality is due to both equipment and method, and has nothing to do with the quality of the product itself. The test data and results shall be discarded and retained, and the above-mentioned batches shall be re-collected for the test of related substances. The sampling sequence in H0-AM-32005 "Precautions for Orlistat Tablet Analysis Method" (applicable to related substances) needs to be upgraded, and the injection needle of the instrument numbered A-CAY-ZKZX-3007 needs to be replaced. In addition, Check whether the injection needles on other HPLC instruments in the laboratory are worn out. If so, contact the engineers of the metrology department for replacement in time.
正在翻译中..